Continuing its momentum in the growing Asia-Pacific markets, Clariant International Ltd. is adding a composite line in Singapore for medical grade resins.

The compounding extruder line will be capable of rapidly producing batches ranging from 1 to 5 tons and more, the company announced at the September Medtec China trade show in Shanghai. Clariant already has one of those lines in operation at its Singapore facility.

“By the time our new composites line goes live in Singapore, Clariant will be able to supply pre-colored composites that address the particular needs of the healthcare industry in the Asia Pacific region,” said Steve Duckworth, Chief of the global segment. doctor and pharmaceutical for the Swiss chemical giant.

“Medical processors can take advantage of our ready-to-use compounds for ease of handling, as well as controlled, consistent and compliant materials,” he said.

At last year’s Chinaplas trade show in Shanghai, Clariant announced an aggressive plan to target the Asia-Pacific region, including sending Christian Kohlpaintner, a member of the company’s four-member executive committee, to Shanghai.

The company is on track to open its Asia Pacific headquarters and R&D center in Shanghai next year.

Earlier this year, Clariant announced plans to add two new production facilities at its Zhenjiang, China plant next year for plastic additives and wax coatings.